Evogene announces amendment to Bayer wheat agreement

Evogene (EVGN) announced an amendment to the remaining work plan under its collaboration with Bayer CropScience LP (BAYRY) for improved wheat. Pursuant to the amended work plan, Evogene will shift from discovery of additional genes and SNP’s to discovery of novel genomic promoters. Under the amended agreement, Evogene will continue in close teamwork with Bayer to utilize its ATHLETE discovery platform but will shift the focus from the discovery of additional genes and SNP's to identifying novel genomic promoters.